AiXin Life International, Inc.
AIXND
Other OTC1.60
USD
- -
- -
CIK
0000835662
Return %
Stock
S&P500
1Y
-83.74
26.53
3Y
-73.33
76.60
5Y
32.45
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Quanzhong Lin
- Full Time Employees
- 217
- Sector
- Consumer Defensive
- Industry
- Food Distribution
- Address
- Hongxing Intl. Business Building 2 Chengdu People's Republic of China
- IPO Date
- Feb 29, 2008
- CIK
- 0000835662
- Website
- aixinjituan.com
- Similar Companies
- Business
- AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements primarily in the People's Republic of China. Its product offerings include herbs, greens, traditional Chinese remedies, and functional products such as weight management tools, probiotics, nutritional foods, and drinks. The company also markets specific branded products including Rhino King, colostrum powder derived from goat's milk, Tong Li Ke, Gammaoling granules, amoxicillin capsules, loratadine tablets, and Fuyang granules. In addition to its product manufacturing and sales, AiXin Life International operates a chain of pharmacies and a hotel business in Sichuan Province. The company operates through four main segments: Products, Pharmacies, Hotel, and Manufacture and Sales. Its distribution channels include company-owned retail offices, pharmacies, direct marketing, e-commerce platforms, exhibitions, conferences, and person-to-person marketing. AiXin Life International also provides marketing and distribution services to other manufacturers and suppliers of healthcare products. Founded in 1987 and headquartered in Chengdu, China, AiXin Life International has faced recent operational challenges. In 2025, the company reported a significant decline in revenue and continued comprehensive losses, citing delays in financial reporting and substantial doubt about its ability to continue as a going concern. Despite these difficulties, the company continues to focus on expanding its healthcare and nutritional product offerings in the growing middle-class market in China. Recent notable events include the company filing a late Form 10-Q in 2025 due to revenue declines and ongoing financial losses, highlighting the critical need for strategic and operational adjustments. No major new partnerships or acquisitions were reported within the last 1-2 years, but the company continues to emphasize product development and direct client engagement through multiple sales and marketing channels. AiXin Life International, Inc. remains positioned in the food distribution and consumer staples sector with a workforce of approximately 120 employees, focusing on health supplements and related products within China’s domestic market. The company operates through its subsidiary AiXinZhonghong for direct sales of nutritional products to clients. This description integrates the company's core product ranges, operational segments, geographic focus, founding and headquarters information, and the latest significant financial and operational developments. AiXin Life International, Inc. is traded under the ticker AIXND on the US OTC market.